Adam Lowy, DPM
Podiatrist · Silver Spring, MDNPI 1477795045
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (59.2%), food and beverage and speaking fees — rather than concentrated in one kind of arrangement. Supreme Orthopedic Systems, LLC accounts for 61.0% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2022 at $1,505 and has fallen 92.8% since, to $109 in 2025.
Across 44 payments — averaging $69.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Supreme Orthopedic Systems, LLC$2K
- Nevro Corp.$192
- Organogenesis Inc.$178
- Smith+Nephew$158
- Musculoskeletal Transplant Foundation Inc.$121
- Acumed LLC$120
- plus $426 from 13 others
What the payments were for
- Speaking & faculty fees$632%
- Food & beverage$1,18639%
- Education$1,81359%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Supreme Orthopedic Systems, LLC | 4 | $1,867 |
| Nevro Corp. | 4 | $192 |
| Organogenesis Inc. | 7 | $178 |
| Smith+Nephew | 8 | $158 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $121 |
| Acumed LLC | 1 | $120 |
| Zimmer Biomet | 2 | $113 |
| ETS Wound Care LLC | 2 | $36 |
| DJO, LLC | 1 | $33 |
| Biocomposites Inc | 1 | $33 |
| Globus Medical | 1 | $30 |
| Convatec Inc. | 2 | $30 |
| Amgen | 1 | $27 |
| Tactile Systems Technology Inc | 2 | $25 |
| Kerecis Limited | 1 | $25 |
| Treace Medical Concepts, Inc. | 1 | $22 |
| Linvatec Corporation | 1 | $19 |
| Triad Life Sciences Inc. | 1 | $18 |
| Abbott | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,062 in reported general payments places this provider in the 75th percentile of 183 podiatrist providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ketoconazole | 52 | $1,666 |
| Gabapentin | 72 | $1,162 |
| Terbinafine Hcl | 49 | $580 |
| Cephalexin | 30 | $234 |
| Methylprednisolone | 18 | $135 |
| Silver Sulfadiazine | 15 | $131 |
| Doxycycline Hyclate | 14 | $97 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $69 |
| Meloxicam | 20 | $37 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Silver Spring
- Holly BeckSilver Spring$15K
- Brandon BlankenSilver Spring$12K
- Haseeb AhmadSilver Spring$9K
- Priya ParthasarathySilver Spring$6K
- Steven BlankenSilver Spring$5K
- Howard OstermanSilver Spring$3K
- Jennifer GerresSilver Spring$3K
- Ijeoma NwujuBethesda$601K
- David Linla Plata$75K
- Ira GottliebPasadena$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.